TY - JOUR
T1 - Cell encapsulation
T2 - technical and clinical advances
AU - Orive, Gorka
AU - Santos, Edorta
AU - Poncelet, Denis
AU - Hernández, Rosa María
AU - Pedraz, José Luis
AU - Wahlberg, Lars U
AU - De Vos, Paul
AU - Emerich, Dwaine
N1 - Copyright © 2015 Elsevier Ltd. All rights reserved.
PY - 2015/8
Y1 - 2015/8
N2 - Treating many chronic diseases will require a tight, minute-to-minute regulation of therapeutic molecules that is currently not achievable with most pharmaceutical therapies. For these diseases, implantable living cellular systems may be able to provide unlimited drug delivery, enabling seamless matching of treatment duration with disease longevity. Cell encapsulation is an advanced technology that achieves this goal and represents a viable therapeutic option. The advanced state of the field has allowed researchers to inch forward into therapeutic domains previously untouchable because of the myriad disparate fields that intersect biomaterials and cells. Here, we discuss the next generation of clinical trials and potential approaches, 'smart' and responsive encapsulation systems, sophisticated and multifunctional devices, and novel imaging tools, together with the future challenges in the field.
AB - Treating many chronic diseases will require a tight, minute-to-minute regulation of therapeutic molecules that is currently not achievable with most pharmaceutical therapies. For these diseases, implantable living cellular systems may be able to provide unlimited drug delivery, enabling seamless matching of treatment duration with disease longevity. Cell encapsulation is an advanced technology that achieves this goal and represents a viable therapeutic option. The advanced state of the field has allowed researchers to inch forward into therapeutic domains previously untouchable because of the myriad disparate fields that intersect biomaterials and cells. Here, we discuss the next generation of clinical trials and potential approaches, 'smart' and responsive encapsulation systems, sophisticated and multifunctional devices, and novel imaging tools, together with the future challenges in the field.
KW - NERVE GROWTH-FACTOR
KW - HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES
KW - ALGINATE-BASED MICROCAPSULES
KW - NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; AMINIATURIZED 3D CULTURE
KW - NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3DTYPE-1 DIABETIC-PATIENT
KW - NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT;PANCREATIC-ISLET CELLS
KW - NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT; PANCREATIC-ISLET CELLSPLURIPOTENT STEM-CELLS
KW - POLY-L-LYSINE
KW - GENE-THERAPY
KW - NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT; PANCREATIC-ISLET CELLS; PLURIPOTENT STEM-CELLS; POLY-L-LYSINE; GENE-THERAPY;NONIMMUNOSUPPRESSED PATIENTS
U2 - 10.1016/j.tips.2015.05.003
DO - 10.1016/j.tips.2015.05.003
M3 - Review article
C2 - 26067102
SN - 0165-6147
VL - 36
SP - 537
EP - 546
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
IS - 8
ER -